Bryan A. Laffitte
Genomics Institute of the Novartis Research Foundation · 44 works · 10,117 citations · h-index 30
Top works
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
- Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
- Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
- Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors
- Synthetic LXR ligand inhibits the development of atherosclerosis in mice
- LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
- Identification of macrophage liver X receptors as inhibitors of atherosclerosis
- Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor
- Autoregulation of the Human Liver X Receptor α Promoter
- Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
- Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: a Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids
- Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages
- Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency
- The Phospholipid Transfer Protein Gene Is a Liver X Receptor Target Expressed by Macrophages in Atherosclerotic Lesions
- Liver X receptors are regulators of adipocyte gene expression but not differentiation
- Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
- GPR68 Senses Flow and Is Essential for Vascular Physiology
- Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
- Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth
- Discovery of Substituted Maleimides as Liver X Receptor Agonists and Determination of a Ligand-Bound Crystal Structure